The most recent version of the European Society for Medical Oncology (ESMO) Clinical
Practice Guidelines for the diagnosis, treatment and follow-up of hepatocellular carcinoma …

Hepatocellular carcinoma (HCC) is a common and deadly cancer. Most cases of HCC arise
in a cirrhotic/fibrotic liver, indicating that environment may play a paramount role in cancer …

Hepatocellular carcinoma (HCC) is a heterogeneous disease that remains highly prevalent
in many Asian countries and is the second most common cause of cancer‐related mortality …

Portal vein tumor thrombus (PVTT) is very common and it plays a major role in the prognosis
and clinical staging of hepatocellular carcinoma (HCC). We have published the first version …

Embolization with microspheres is a therapeutic strategy based on the selective occlusion of
the blood vessels feeding a tumor. This procedure is intraarterially performed in the clinical …

Hepatic malignancies remain a global challenge. Hepatocellular carcinoma (HCC) accounts
for around 90% of patients with liver cancer and is the sixth most common neoplasm …

Hepatocellular carcinoma (HCC) is the most common primary liver malignancy and third
leading cause of cancer-related mortality worldwide. While surgical resection and …

Clinical practice of transarterial chemoembolization for hepatocellular carcinoma: consensus
statement from an international expert panel of International Society of Multidisciplinary …

Highlights•The incidence of HCC will continue to rise.•HCC is curable at an early
stage.•New locoregional treatments such as radioembolisation are showing impressive …

Purpose To conduct a large single-institution comparison of transarterial chemoembolization
(TACE) and stereotactic body radiation therapy (SBRT) outcomes in similar groups of …